Rare diseases
Investigational molecules
Locations
Teutoburger Str. 60, 33604 Bielefeld, Germany
Onkologische Schwerpunktpraxis Bielefeld in Bielefeld, Germany specialises in clinical trials of conditions such as Colon cancer stage III, Colon cancer stage IV, HER2 positive breast cancer, and other specialisations. This site conducts important research.
At the Onkologische Schwerpunktpraxis Bielefeld, investigators are focusing on advanced colon cancer stages T3‑4, evaluating the impact of pre‑surgical systemic therapy compared with standard surgery followed by stage‑guided adjuvant treatment.
These studies aim to improve outcomes for patients with high‑risk disease and demonstrate the site’s dedication to personalized cancer care in Bielefeld.
The same center is also conducting research on high‑risk HER2‑positive breast cancer, comparing the novel antibody‑drug conjugate T‑DXd with the established therapy T‑DM1 to determine which provides better invasive disease‑free survival for patients with residual disease after neoadjuvant treatment.
Both trials reflect the site’s commitment to advancing oncologic therapies and improving patient outcomes across Europe.
Clinical trials currently enrolling participants at this site.
GermanyGermanyGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
